These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 27746411

  • 1. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease　- A Multicenter Retrospective Study.
    Okuma Y, Suda K, Nakaoka H, Katsube Y, Mitani Y, Yoshikane Y, Ichida F, Matsushita T, Shichino H, Shiraishi I, Abe J, Hiroe M, Yoshida T, Imanaka-Yoshida K.
    Circ J; 2016 Oct 25; 80(11):2376-2381. PubMed ID: 27746411
    [Abstract] [Full Text] [Related]

  • 2. Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study.
    Yoshikane Y, Okuma Y, Miyamoto T, Hashimoto J, Fukazawa R, Kato T, Takeda A, Suda K, Matsushita T, Hiroe M, Imanaka-Yoshida K.
    Pediatr Rheumatol Online J; 2021 Jun 05; 19(1):82. PubMed ID: 34090475
    [Abstract] [Full Text] [Related]

  • 3. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
    J Pediatr; 2013 Jun 05; 162(6):1205-9. PubMed ID: 23290510
    [Abstract] [Full Text] [Related]

  • 4. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
    [Abstract] [Full Text] [Related]

  • 5. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Sep 27; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 6. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
    Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, Takahashi K, Okada S, Wakiguchi H, Moriwake T, Uchida M, Ohbuchi N, Iwai T, Hasegawa M, Ichihara K, Yashiro M, Makino N, Nakamura Y, Ohga S.
    Int J Cardiol; 2016 Jul 01; 214():209-15. PubMed ID: 27070994
    [Abstract] [Full Text] [Related]

  • 7. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec 01; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 8. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Dec 01; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 9. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E, Małecka-Tendera E, Gawlik T, Firek-Pędras M, Szydłowski L, Gawlik A.
    Kardiol Pol; 2017 Dec 01; 75(3):261-266. PubMed ID: 27995598
    [Abstract] [Full Text] [Related]

  • 10. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 11. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q, Zhou TF, Chen CH, Hua YM, Liu HM, Hong H, Zhang LY, Wu Q.
    Zhonghua Er Ke Za Zhi; 2005 Sep 21; 43(9):676-80. PubMed ID: 16191301
    [Abstract] [Full Text] [Related]

  • 12. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.
    Oncotarget; 2017 Jan 10; 8(2):2044-2052. PubMed ID: 27893416
    [Abstract] [Full Text] [Related]

  • 13. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y, Wu J, Fang XY, Lin Z, Wu BY, Cai RY, Xu XY, Zheng H.
    Zhonghua Er Ke Za Zhi; 2004 Sep 10; 42(9):688-92. PubMed ID: 15482673
    [Abstract] [Full Text] [Related]

  • 14. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA.
    Arch Dis Child; 2015 Apr 10; 100(4):366-8. PubMed ID: 25670405
    [Abstract] [Full Text] [Related]

  • 15. Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease.
    Kanamitsu K, Kakimoto H, Shimada A, Nakata Y, Ochi H, Watanabe H, Iwasaki Y, Tokorodani C, Kanazawa A, Maruyama H, Miyazawa M, Nishiuchi R, Kikkawa K.
    Pediatr Int; 2016 Feb 10; 58(2):146-51. PubMed ID: 26190225
    [Abstract] [Full Text] [Related]

  • 16. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
    Wei M, Huang M, Chen S, Huang G, Huang M, Qiu D, Guo Z, Jiang J, Zhou X, Yu Q, Guo Y, Fu L, Gao W, Li F.
    Pediatr Cardiol; 2015 Aug 10; 36(6):1166-72. PubMed ID: 25812827
    [Abstract] [Full Text] [Related]

  • 17. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
    Int J Rheum Dis; 2013 Apr 10; 16(2):168-72. PubMed ID: 23773640
    [Abstract] [Full Text] [Related]

  • 18. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec 10; 15(12):1109-12. PubMed ID: 24342209
    [Abstract] [Full Text] [Related]

  • 19. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
    Li W, Zhang L, Wang Z, He X, Lin H, Wang Y, Yuan J, Xie X, Zhang X, Qin Y, Huang P.
    Int J Clin Pract; 2022 Dec 10; 2022():2726686. PubMed ID: 35989868
    [Abstract] [Full Text] [Related]

  • 20. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
    Paediatr Int Child Health; 2018 Aug 10; 38(3):209-212. PubMed ID: 29768976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.